Sirona Biochem Provides Financial and Operational Update
Sirona Biochem, a cosmetic ingredient and drug discovery company, is facing significant financial distress, culminating in the liquidation of...
No videos found.
Susvimo Maintains Vision in NAMD Patients Over 5 Years
Roche’s Susvimo secures five-year efficacy and safety data in neovascular age-related macular degeneration (nAMD), potentially reshaping the treatment landscape...
Artelo Gets UK Green Light for Phase 1 CBD Trial in Anxiety & Depression
Artelo Biosciences has secured positive scientific advice from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its...
Orchestra Biomed Gets $70M from Medtronic and Ligand
Orchestra Biomed Secures $70M in Strategic Funding, Signaling Growing Confidence in Late-Stage Cardiology Programs Orchestra Biomed has secured $70...
Liminatus Pharma Launches American BNB Strategy
Liminatus Pharma, a preclinical biopharmaceutical company, is making a striking move into the cryptocurrency market, planning to acquire up...
Bio Usawa & DEK Vaccines Partner to Expand Biopharma Access in Ghana
Bio Usawa and DEK Forge Partnership to Tackle Africa’s Growing Non-Communicable Disease Burden Bio Usawa, a private biotech company...
Branded Legacy to Acquire Bio-Legacy, Advancing Nasal Drug Delivery
Branded Legacy, Inc., a diversified holdings company, is poised to enter the burgeoning naloxone and vaccine markets through a...
Vivex Completes ASCEND Trial Enrollment for Disc Degeneration
Vivex Biologics has completed patient enrollment in its ASCEND trial, a pivotal study evaluating VIA Disc NP, a novel...
Duravyu™ Phase 3 Wet AMD Trial Enrollment Complete
EyePoint Pharmaceuticals has achieved full enrollment in its LUCIA trial, the second of two pivotal Phase 3 studies evaluating...
Serina Therapeutics to Develop Novel TD Treatment
Serina Therapeutics is advancing SER-270 (POZ-VMAT2i), a once-weekly injectable vesicular monoamine transporter 2 (VMAT2) inhibitor, for tardive dyskinesia (TD)....